MX2020002235A - Composicion para la estimulacion ovarica controlada. - Google Patents
Composicion para la estimulacion ovarica controlada.Info
- Publication number
- MX2020002235A MX2020002235A MX2020002235A MX2020002235A MX2020002235A MX 2020002235 A MX2020002235 A MX 2020002235A MX 2020002235 A MX2020002235 A MX 2020002235A MX 2020002235 A MX2020002235 A MX 2020002235A MX 2020002235 A MX2020002235 A MX 2020002235A
- Authority
- MX
- Mexico
- Prior art keywords
- composition
- ovarian stimulation
- controlled ovarian
- controlled
- fsh
- Prior art date
Links
- 230000002611 ovarian Effects 0.000 title 1
- 230000000638 stimulation Effects 0.000 title 1
- 230000037396 body weight Effects 0.000 abstract 1
- 208000000509 infertility Diseases 0.000 abstract 1
- 230000036512 infertility Effects 0.000 abstract 1
- 231100000535 infertility Toxicity 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Reproductive Health (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Gynecology & Obstetrics (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Pregnancy & Childbirth (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Preparaciones que incluyen FSH, por ejemplo, FSH recombinante, para el uso en el tratamiento de la infertilidad en pacientes que tienen AMH alta y peso corporal bajo.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP17189119 | 2017-09-01 | ||
PCT/EP2018/073442 WO2019043143A1 (en) | 2017-09-01 | 2018-08-31 | COMPOSITION FOR CONTROLLED OVARIAN STIMULATION |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2020002235A true MX2020002235A (es) | 2020-07-20 |
Family
ID=59772482
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2020002235A MX2020002235A (es) | 2017-09-01 | 2018-08-31 | Composicion para la estimulacion ovarica controlada. |
Country Status (30)
Country | Link |
---|---|
US (2) | US11744879B2 (es) |
EP (2) | EP3675894B1 (es) |
JP (2) | JP6856819B2 (es) |
KR (1) | KR20200045543A (es) |
CN (1) | CN111050787A (es) |
AR (1) | AR112541A1 (es) |
AU (1) | AU2018326556A1 (es) |
BR (1) | BR112020003379A2 (es) |
CA (1) | CA3073624A1 (es) |
CL (1) | CL2020000482A1 (es) |
DK (1) | DK3675894T3 (es) |
EA (1) | EA202090480A1 (es) |
ES (1) | ES2904787T3 (es) |
HR (1) | HRP20211802T1 (es) |
HU (1) | HUE056726T2 (es) |
IL (1) | IL272763B2 (es) |
JO (1) | JOP20200034A1 (es) |
LT (1) | LT3675894T (es) |
MA (2) | MA50034B1 (es) |
MD (1) | MD3675894T2 (es) |
MX (1) | MX2020002235A (es) |
PH (1) | PH12020500404A1 (es) |
PL (1) | PL3675894T3 (es) |
PT (1) | PT3675894T (es) |
RS (1) | RS62810B1 (es) |
SG (1) | SG11202003840QA (es) |
SI (1) | SI3675894T1 (es) |
TW (1) | TWI749255B (es) |
UA (1) | UA126869C2 (es) |
WO (1) | WO2019043143A1 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW202237173A (zh) * | 2020-12-09 | 2022-10-01 | 荷蘭商菲林公司 | 用於受控的卵巢刺激之組成物及方法 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR0107881A (pt) * | 2000-01-27 | 2003-04-01 | Applied Research Systems | Uso de fsh tratamento de infertilidade |
US20040248784A1 (en) | 2003-06-03 | 2004-12-09 | Marco Filicori | Unitary combinations of FSH and hCG |
ES2494928T3 (es) * | 2007-09-21 | 2014-09-16 | Pharmabrand S.A. | Composición que comprende polisacáridos mucilaginosos derivados de Aloe barbadensis combinados con liposomas, procedimiento para la obtención de los mismos y su uso como protector solar, un agente antiacné, un regenerador epidérmico y un hidratante |
TWI488640B (zh) | 2008-04-16 | 2015-06-21 | Ferring Int Ct Sa | 藥學製劑 |
WO2011089602A2 (en) * | 2010-01-21 | 2011-07-28 | Ramot At Tel-Aviv University Ltd. | Aloe-emodin derivatives and use thereof for the treatment of cancer |
US9320778B2 (en) | 2010-09-29 | 2016-04-26 | Ferring B.V. | Method for controlled ovarian stimulation with combined FSH and hCG |
AR090095A1 (es) | 2011-06-06 | 2014-10-22 | Ferring Bv | Preparacion farmaceutica que comprende hormona estimulante del foliculo recombinante |
JO3092B1 (ar) | 2011-08-08 | 2017-03-15 | Ferring Bv | مركب لتحفيز مسيطر عليه للمبيض |
SG11201608132UA (en) * | 2014-04-18 | 2016-11-29 | Glycotope Gmbh | Controlled ovarian hyperstimulation with improved recombinant human follicle-stimulating hormone |
PL3261661T3 (pl) | 2015-02-26 | 2024-03-25 | Ferring B.V. | Menotropina do leczenia niepłodności |
SI3662925T1 (sl) | 2015-04-17 | 2021-08-31 | Ferring B.V. | Sestavek, ki vsebuje FSH za zdravljenje neplodnosti |
LT3286209T (lt) | 2015-04-24 | 2021-02-25 | Ferring Bv | Gonadotropino gamybos būdas |
KR20180020982A (ko) | 2015-06-26 | 2018-02-28 | 훼링 비.브이. | 정제 방법 및/또는 바이러스 불활화 처리 방법 |
JP2021522268A (ja) | 2018-04-30 | 2021-08-30 | フェリング ベスローテン フェンノートシャップ | 制御された卵巣刺激のための組成物 |
CA3110205A1 (en) | 2018-10-17 | 2020-04-23 | Ferring Bv | Compositions and methods for controlled ovarian stimulation |
-
2018
- 2018-08-31 IL IL272763A patent/IL272763B2/en unknown
- 2018-08-31 EP EP18768795.9A patent/EP3675894B1/en active Active
- 2018-08-31 MA MA50034A patent/MA50034B1/fr unknown
- 2018-08-31 LT LTEPPCT/EP2018/073442T patent/LT3675894T/lt unknown
- 2018-08-31 HU HUE18768795A patent/HUE056726T2/hu unknown
- 2018-08-31 TW TW107130683A patent/TWI749255B/zh active
- 2018-08-31 JP JP2020512546A patent/JP6856819B2/ja active Active
- 2018-08-31 PL PL18768795T patent/PL3675894T3/pl unknown
- 2018-08-31 RS RS20220042A patent/RS62810B1/sr unknown
- 2018-08-31 AR ARP180102492 patent/AR112541A1/es unknown
- 2018-08-31 WO PCT/EP2018/073442 patent/WO2019043143A1/en unknown
- 2018-08-31 PT PT187687959T patent/PT3675894T/pt unknown
- 2018-08-31 MX MX2020002235A patent/MX2020002235A/es unknown
- 2018-08-31 EA EA202090480A patent/EA202090480A1/ru unknown
- 2018-08-31 MA MA056224A patent/MA56224A/fr unknown
- 2018-08-31 US US16/642,777 patent/US11744879B2/en active Active
- 2018-08-31 EP EP21196378.0A patent/EP3973982B1/en active Active
- 2018-08-31 CN CN201880055934.1A patent/CN111050787A/zh active Pending
- 2018-08-31 CA CA3073624A patent/CA3073624A1/en active Pending
- 2018-08-31 HR HRP20211802TT patent/HRP20211802T1/hr unknown
- 2018-08-31 MD MDE20200700T patent/MD3675894T2/ro unknown
- 2018-08-31 UA UAA202002175A patent/UA126869C2/uk unknown
- 2018-08-31 SI SI201830484T patent/SI3675894T1/sl unknown
- 2018-08-31 JO JOP/2020/0034A patent/JOP20200034A1/ar unknown
- 2018-08-31 ES ES18768795T patent/ES2904787T3/es active Active
- 2018-08-31 BR BR112020003379-0A patent/BR112020003379A2/pt unknown
- 2018-08-31 SG SG11202003840QA patent/SG11202003840QA/en unknown
- 2018-08-31 AU AU2018326556A patent/AU2018326556A1/en active Pending
- 2018-08-31 KR KR1020207009105A patent/KR20200045543A/ko not_active Application Discontinuation
- 2018-08-31 DK DK18768795.9T patent/DK3675894T3/da active
-
2020
- 2020-02-27 CL CL2020000482A patent/CL2020000482A1/es unknown
- 2020-02-28 PH PH12020500404A patent/PH12020500404A1/en unknown
- 2020-10-30 JP JP2020182295A patent/JP7373479B2/ja active Active
-
2023
- 2023-07-25 US US18/226,206 patent/US20240024424A1/en active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12020551923A1 (en) | Methods and compositions for treating cancer | |
MX2018005315A (es) | Composiciones y metodos para el tratamiento del cancer. | |
MX2019010040A (es) | Composiciones y métodos para el tratamiento del cáncer. | |
MX2016012574A (es) | Compuestos heteroarilo sustituidos y metodos de uso. | |
JO3092B1 (ar) | مركب لتحفيز مسيطر عليه للمبيض | |
EP4218809A3 (en) | Combination therapy using inhibitors of human growth and differentiation factor 15 (gdf-15) and immune checkpoint blockers | |
MX2017010883A (es) | Composicion para el tratamiento de la infertilidad. | |
MY196448A (en) | Anti-Htra1 Antibodies and Methods of use Thereof | |
MD3768284T2 (ro) | Compoziţii de entrecoccus flagellin pentru utilizare în terapie | |
PH12017501300A1 (en) | Novel iodophor composition and methods of use | |
MX2018008645A (es) | Derivados de 8-amino-2-oxo-1,3-diaza-espiro-[4.5]-decano. | |
PH12021550122A1 (en) | Solubilized apyrases, methods and use | |
MX2019015676A (es) | Uso de isovaleril espiramicina i, ii y/o iii en la fabricación de medicamentos para el tratamiento y/o la prevención de tumores, y el medicamento. | |
MX2021004755A (es) | Uso de plasma y fracciones de plasma para mejorar el dolor, la cicatrizacion de heridas y la recuperacion posoperatoria. | |
MX2020003762A (es) | Composiciones cosmeticas y metodo para tratar la piel. | |
NZ745187A (en) | 3-(carboxyethyl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives | |
MX2018002921A (es) | Composicion de hormona foliculo-estimulante mamifera con estabilidad incrementada. | |
NZ762312A (en) | Anti-pacap antibody | |
PH12020500079A1 (en) | Novel substituted xanthine derivates | |
MX2021006102A (es) | Suministro mejorado de agentes grandes. | |
MX2020001632A (es) | Composiciones que comprenden cepas bacterianas. | |
PH12020500404A1 (en) | Composition for controlled ovarian stimulation | |
PH12021550121A1 (en) | Methods of treating hfpef employing dapagliflozin and compositions comprising the same | |
MX2017013879A (es) | Composiciones que comprenden anakinra. | |
MX2019009293A (es) | Compuestos, composiciones y usos de los mismos para la mejoria de trastornos oseos. |